Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 1 - 5 out of 315
Li, E, Boujeddaine, N, Houtman, MJC, Maas, RGC, Sluijter, JPG, Ecker, GF, Stary-Weinzinger, A, van Ham, WB & van der Heyden, MAG 2025, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology, vol. 182, no. 3, pp. 633-650. https://doi.org/10.1111/bph.17377
Magel, V, Blum, J, Dolde, X, Leisner, H, Grillberger, K, Khalidi, H, Gardner, I, Ecker, GF, Pallocca, G, Dreser, N & Leist, M 2024, 'Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants', Cells, vol. 13, no. 24, 2057. https://doi.org/10.3390/cells13242057
Li, E, Boujeddaine, N, Houtman, MJC, Maas, Sluijter, , Ecker, G, Weinzinger, A, van Ham, W & van der Heyden, M 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology. <https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.17377>
Ortega-Vallbona, R, Palomino-Schätzlein, M, Tolosa, L, Benfenati, E, Ecker, GF, Gozalbes, R & Serrano-Candelas, E 2024, 'Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study', International Journal of Molecular Sciences, vol. 25, no. 20, 11154. https://doi.org/10.3390/ijms252011154
Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599
Activities
Showing entries 71 - 75 out of 203
Valerenic Acid as a Model Compound for New GABAA Receptor Ligands.
Maximilian Haider
,
Gerhard Ecker
,
Steffen Hering
,
Marko Mihovilovic
22nd International Symposium on Medicinal Chemistry (EFMC-ISMC 2012)
Conference,
Poster presentation
..2012 - ..2012
Classification of an Imbalanced Dataset of P-Glycoprotein Substrates and Non-substrates using Cost-Sensitive Machine Learning Methods.
Yogesh Aher
,
Vasanthanathan Poongavanam
,
Gerhard Ecker
Joint Meeting of the Austrian and German Pharmaceutical Societies
Conference,
Poster presentation
..2011 - ..2011
Evaluation of Drug Binding Modes in a Series of Homology Models of the Gamma-Aminobutyric Acid Transporter.
Andreas Jurik
,
Regina Reicherstorfer
,
Barbara Zdrazil
,
Ernst Urban
,
Gerhard Ecker
8th European Workshop in Drug Design
Seminar/Workshop,
Poster presentation
..2011 - ..2011
Exhaustive docking protocol with SAR-based pose selection.
Freya Klepsch
,
Gerhard Ecker
241st American Chemical Society National Meeting & Exposition (ACS 2011)
Conference,
Poster presentation
..2011 - ..2011
In silico prediction of ABCC2 substrate specificity.
Marta Pinto
,
Gerhard Ecker
Joint Meeting of the Austrian and German Pharmaceutical Societies
Conference,
Poster presentation
..2011 - ..2011